Cherry Tree Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293 Hold
1
﹤0.01% 574
2025
Q4
$351 Sell
1
-13
-93% -$4.39K ﹤0.01% 575
2025
Q3
$4.52K Hold
14
﹤0.01% 478
2025
Q2
$5.45K Sell
14
-39
-74% -$15.7K ﹤0.01% 466
2025
Q1
$23.1K Buy
53
+20
+61% +$8.03K 0.01% 329
2024
Q4
$12.2K Hold
33
﹤0.01% 386
2024
Q3
$17.2K Hold
33
﹤0.01% 361
2024
Q2
$17.9K Buy
33
+14
+74% +$7.4K ﹤0.01% 340
2024
Q1
$9.85K Hold
19
﹤0.01% 380
2023
Q4
$8.96K Hold
19
﹤0.01% 363
2023
Q3
$8.27K Hold
19
﹤0.01% 357
2023
Q2
$8.44K Buy
+19
New +$8.77K ﹤0.01% 350

Other funds holding ELV

Cherry Tree Wealth Management's ELV Position: Q1 2026 in Review

Cherry Tree Wealth Management held its Elevance Health (ELV) position steady in Q1 2026 at 1 share worth $293. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Cherry Tree Wealth Management first reported a position in ELV in Q2 2023 and has held it in 12 quarters since. The position peaked at $23.1K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Cherry Tree Wealth Management held 1 share of Elevance Health worth $293 as of Q1 2026.
  • Cherry Tree Wealth Management left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #574 holding.
  • Cherry Tree Wealth Management first reported a position in Elevance Health in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Elevance Health position peaked at $23.1K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.